MedPath

Artificial Induction of Labour in Full-term Singleton Pregnancy : Comparative Randomized Trial of Two Strategies

Not Applicable
Completed
Conditions
Pregnancy Related
Interventions
Procedure: Vaginal Dinoprostone system (Propess®)
Procedure: Dilatation balloon
Registration Number
NCT04452747
Lead Sponsor
University Hospital, Montpellier
Brief Summary

Labour induction is an obstetrical procedure, which artificially starts the process of cervix dilation, in order to induce labour. Several methods of labour induction exist : mechanical ones (using dilatation balloons) or pharmacological ones (using prostaglandins or oxytocin). This trial aims to compare, in case of non-favourable cervix, the strategy of labour induction using the Propess® method first (Dino-first) versus the strategy beginning with the use of a dilatation balloon (Ballon-first), with respect of the usual practice and the current guidelines.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
450
Inclusion Criteria
  • Women with singleton pregnancy
  • Fetus with cephalic presentation
  • Intact membranes between 37 and 42 weeks of amenorrhea
  • Medical indication for labour induction according to the "Haute Autorité de Santé" (HAS) guidelines
  • Unfavourable cervix (Bishop scoring < 7)
  • Age > 18 years-old
  • Person affiliated to a healthcare system
  • Good understanding of the French language
Exclusion Criteria
  • Previous C-section or uterine incision
  • Placenta previa
  • Metrorrhagia of unknown origin
  • Lethal foetal abnormality
  • Hyperreactivity to one of the molecules used for the induction (dinoprostone or oxytocin) or to latex
  • Subject participants to another biomedical research
  • Subject under legal guardianship or curatorship

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dino-firstVaginal Dinoprostone system (Propess®)Labour will be induced by the use of the vaginal Dinoprostone system (Propess®) first.
Balloon-firstDilatation balloonLabour will be induced by the use of a cervix dilatation balloon first.
Primary Outcome Measures
NameTimeMethod
Rate of vaginal deliveriesOn the day of the delivery

Rate of vaginal deliveries (both spontaneous or instrumentally assisted)

Secondary Outcome Measures
NameTimeMethod
Rate of metrorrhagias while putting in place the dilatation balloon or the vaginal pad (dinoprostone)On the day of the delivery

Number of women who experienced metrorrhagias while putting in place the dilatation balloon or the vaginal pad (dinoprostone)

Assessment of the patient experience of the labour inductionUp to two weeks after the delivery

Patient experience will be assessed using the W-DEQ (Wijma Delivery Expectancy/Experience Questionnaire)

Assessment of each strategy direct main coststhrough study completion, an average of 3 years

The costs of the treatment and duration of the hospitalization will be measured

Rate of labour induction failureOn the day of the delivery

Rate of labour induction failure is measure by the number of C-sections carried out due to a latency phase (0-6cm), which lasted more than 24 hours, together with the administration of oxytocin for at least 12 to 18 hours after the membranes artifically broke.

Rate of uterine ruptureOn the day of the delivery

Number of patients with a uterine rupture

Rate of neonatal asphyxiaOn the day of the delivery

Number of fetuses with neonatal asphyxia

Rate of hospitalization in Neonatal intensive care unitUp to four days after the delivery

Number of newborn babies hospitalized in Neonatal intensive care unit

Pain level recorded at different times of the labour inductionOn the day of the delivery

Measurement will be made using a Visual Analog Scale (VAS) and will be recorded at different times of the dilatation balloon or the dinoprostone vaginal pad set up

Rate of spontaneous vaginal deliveriesOn the day of the delivery

Number of spontaneous vaginal deliveries

Rate of secondary or tertiary use of Propess, Foley catheter of intra-veinous oxytocinOn the day of the delivery

Number of secondary or tertiary use of Propess, Foley catheter of intra-veinous oxytocin

Rate of instrumentally assisted vaginal deliveries, including the reason for the assistanceOn the day of the delivery

Number of instrumentally assisted vaginal deliveries, including the reason for the assistance

Rate of C-section including the reason for the C-sectionOn the day of the delivery

Number of C-section including the reason for the C-section. The reasons for the C-section can be : a failure of dilatation at the first stage of the labour (between 0 and 10 cm), an absence of foetal descent at the second stage of labour, a foetal reason or a maternal reason)

Timeframe between the beginning of the induction and the beginning of the labourOn the day of the delivery

Time elapsed between the beginning of the induction and the beginning of the labour

Cumulated rate of spontaneous vaginal deliveriesat 12 hours, 24 hours and 48 hours

Cumulated number of spontaneous vaginal deliveries at 12 hours, 24 hours and 48 hours

Rate of peridural anaesthesia during labourOn the day of the delivery

Number of peridural anaesthesia during labour

Rate of uterine hyperstimulation with an impact on the foetusOn the day of the delivery

Uterine hyperstimulation is described as a number of contractions of 6 or more within 10 minutes, repeating at least twice). Foetal impact is defined as a slowing of the foetal heart rate.

Rate of uterine hyperstimulation without impact on the foetusOn the day of the delivery

Uterine hyperstimulation is described as a number of contractions of 6 or more within 10 minutes, repeating at least twice). Foetal impact is defined as a slowing of the foetal heart rate.

Rate of uterine hypertoniaOn the day of the delivery

Uterine hypertonia is describes as a frequency of contractions every 2 minutes or less together with a slowing of the foetal heart rate.

Rate of post-partum haemorrhagiaOn the day of the delivery

Rate of post-partum haemorrhagia above 500 mL, above 1000 mL, transfusion level and number of packed red blood cells transfused

Pain level linked to the inflation of the dilatation balloon and requiring the partial deflation of the balloonOn the day of the delivery

Measurement of Pain will be made using an Visual Analog Scale (VAS). The pain level will be linked to the inflation of the dilatation balloon and requiring the partial deflation of the balloon

Rate of intra-uterine infectionsOn the day of the delivery

Number of patients with intra-uterine infections (body temperature above 38°C measured twice within 30 minutes, associated to 2 criteria within the followings: foetal tachycardia above 160 beats per minute, pain of the uterus or painful uterus contractions ou spontaneous labour induction, or purulent amniotic fluid.

Rate of post-partum infectionsOne week after day of the delivery

Number of patients with post-partum infections (body temperature above 38°C with antibiotic treatment, urinary tract infections, bacteriological endometritis)

Rate of proven bacteriological infections in newborn babiesUp to four days after the delivery

Number of proven bacteriological infections in newborn babies

Trial Locations

Locations (2)

Montpellier University Hospital

🇫🇷

Montpellier, France

Nimes University Hospital

🇫🇷

Nîmes, France

© Copyright 2025. All Rights Reserved by MedPath